Bausch & Lomb Corp
BLCO- Exchange
- NYSE
- Industry
- Ophthalmic Goods
- SEC CIK
- 0001860742
In the last 90 days, Bausch & Lomb Corp insiders filed 0 open-market purchases and 2 sales; 99 institutions reported holding it in 13F filings for Q2 2026, worth $638.7M in total; 3 superinvestors hold it, including Icahn Capital and Oaktree Capital.
Superinvestors holding BLCO, Q2 2026
3 superinvestors report holding Bausch & Lomb Corp on Form 13F, worth $116.4M in total. Weight is Bausch & Lomb Corp's share of each 13F portfolio; actions compare shares with Q1 2026.
| Superinvestor | % of portfolio | Shares | Value | vs. previous quarter |
|---|---|---|---|---|
| Icahn CapitalCarl Icahn | 0.7% | 3,500,000 | $58.0M | Unchanged |
| Oaktree CapitalHoward Marks | 1.1% | 3,441,042 | $57.0M | Added+1.7% |
| Third PointDaniel Loeb | <0.1% | 85,000 | $1.41M | New |
Moves by quarter
Superinvestors that opened, added to, trimmed or sold out of BLCO each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.
Q2 2026
3 superinvestors holding at quarter end
- New
- Third Point
- Added
- Oaktree Capital (+1.7%)
Q1 2026
2 superinvestors holding at quarter end
- Sold out
- Maverick Capital
Q4 2025
3 superinvestors holding at quarter end
- Added
- Oaktree Capital (+4.2%)
- Reduced
- Maverick Capital (−14.4%)
Q3 2025
3 superinvestors holding at quarter end
- New
- Maverick Capital
- Added
- Oaktree Capital (+28.7%)
Q2 2025
2 superinvestors holding at quarter end
Q2 2022
1 superinvestor holding at quarter end